Neurotherapeutics

, Volume 14, Issue 1, pp 199–211

Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model

  • Begoña M. Escribano
  • Francisco J. Medina-Fernández
  • Macarena Aguilar-Luque
  • Eduardo Agüera
  • Montserrat Feijoo
  • Fe I. Garcia-Maceira
  • Rafael Lillo
  • Patricia Vieyra-Reyes
  • Ana I. Giraldo
  • Evelio Luque
  • René Drucker-Colín
  • Isaac Túnez
Original Article

DOI: 10.1007/s13311-016-0480-0

Cite this article as:
Escribano, B.M., Medina-Fernández, F.J., Aguilar-Luque, M. et al. Neurotherapeutics (2017) 14: 199. doi:10.1007/s13311-016-0480-0

Abstract

Recent findings in experimental autoimmune encephalomyelitis (EAE) suggest that altering certain bacterial populations present in the gut may lead to a proinflammatory condition, that could result in the development of multiple sclerosis (MS). Also, Reactive Oxygen Species seem to be involved in the course of MS. In this study, it has been aimed to relate all these variables starting from an analysis of the lipopolysaccharide (LPS) and LPS-binding protein (LBP) with the determination of parameters related to oxidative stress in the blood, brain and spinal cord. For this purpose, samples obtained from EAE rats and relapsing-remitting (RRMS) MS patients were used. In addition, EAE rats were treated with Natalizumab, N-acetyl-cysteine and dimethyl fumarate. Natalizumab was also employed in RRMS. The results of this study revealed an improvement in the clinical symptoms of the EAE and MS with the treatments, as well as a reduction in the oxidative stress parameters and in LBP. Correlations between the clinical variables of the disease, i.e. oxidative damage and LBP, were established. Although the conclusions of this research are indeed relevant, further investigation would be necessary to establish the intrinsic mechanisms of the MS-oxidative stress-microbiota relationship.

Keywords

Dimethyl fumarate Experimental autoimmune encephalomyelitis Lipopolysaccharide binding protein Natalizumab Oxidative stress Relapsing-remitting multiple sclerosis 

Supplementary material

13311_2016_480_Fig8_ESM.jpg (48 kb)
Supplementary Material S1

(JPG 47 kb)

13311_2016_480_MOESM1_ESM.tiff (94 kb)
High resolution image (TIFF 93 kb)
13311_2016_480_MOESM2_ESM.docx (15 kb)
Supplementary Material S2(DOCX 15 kb)
13311_2016_480_MOESM3_ESM.doc (34 kb)
Supplementary Material S3(DOC 33 kb)
13311_2016_480_Fig9_ESM.jpg (203 kb)
Supplementary Material S4

(JPG 203 kb)

13311_2016_480_MOESM4_ESM.tif (1.4 mb)
High resolution image (TIF 1445 kb)
13311_2016_480_Fig10_ESM.jpg (343 kb)
Supplementary Material S5

(JPG 343 kb)

13311_2016_480_MOESM5_ESM.tif (2.1 mb)
High resolution image (TIF 2121 kb)
13311_2016_480_MOESM6_ESM.pdf (498 kb)
ESM 6(PDF 498 kb)

Funding information

Funder NameGrant NumberFunding Note
Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba

    Copyright information

    © The American Society for Experimental NeuroTherapeutics, Inc. 2016

    Authors and Affiliations

    • Begoña M. Escribano
      • 1
      • 2
    • Francisco J. Medina-Fernández
      • 2
      • 3
    • Macarena Aguilar-Luque
      • 2
      • 3
    • Eduardo Agüera
      • 2
      • 4
    • Montserrat Feijoo
      • 2
      • 3
    • Fe I. Garcia-Maceira
      • 5
    • Rafael Lillo
      • 2
      • 6
    • Patricia Vieyra-Reyes
      • 7
    • Ana I. Giraldo
      • 2
      • 3
    • Evelio Luque
      • 2
      • 8
    • René Drucker-Colín
      • 9
    • Isaac Túnez
      • 2
      • 3
      • 10
    1. 1.Departamento de Biologia Celular, Fisiologia e Inmunologia, Facultad de VeterinariaUniversidad de CordobaCordobaSpain
    2. 2.Instituto Maimonides de Investigacion Biomedica de Cordoba (IMIBIC)CordobaSpain
    3. 3.Departamento de Bioquimica y Biologia Molecular, Facultad de MedicinaUniversidad de CordobaCordobaSpain
    4. 4.Servicio de NeurologíaHospital Universitario Reina Sofía de CordobaCordobaSpain
    5. 5.Canvax Biotech SLCordobaSpain
    6. 6.Departamento de Ciencias Sociosanitarias y Radiologia y Medicina Fisica, Seccion de Psiquiatria, Facultad de MedicinaUniversidad de CordobaCordobaSpain
    7. 7.Departamento Neurofisiología de la Conducta, Facultad de MedicinaUniversidad Autonoma del Estado de MéxicoTolucaMexico
    8. 8.Departamento de Ciencias Morfologicas, Seccion Histologia, Facultad de MedicinaUniversidad de CordobaCordobaSpain
    9. 9.Departamento de Neuropatologia Molecular, Instituto de Fisiologia CelularUniversidad Nacional Autonoma de Mexico (UNAM)Ciudad de MexicoMexico
    10. 10.Red Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF)CordobaSpain

    Personalised recommendations